CASP8 and cancer: Specifically, we evaluated the influence of JTT on lymphocyte viability and immunophenotype in cancer patients, determined the optimal in vitro culture conditions and dosage, and examined its regulatory effects on Jurkat T cell apoptosis through caspase-8 and caspase-3 activation.